Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;18(3):e293-e303.
doi: 10.1200/OP.21.00351. Epub 2021 Sep 28.

Physician Influence on Variation in Receipt of Aggressive End-of-Life Care Among Women Dying of Ovarian Cancer

Affiliations

Physician Influence on Variation in Receipt of Aggressive End-of-Life Care Among Women Dying of Ovarian Cancer

Megan A Mullins et al. JCO Oncol Pract. 2022 Mar.

Abstract

Purpose: End-of-life care for women with ovarian cancer is persistently aggressive, but factors associated with overuse are not well understood. We evaluated physician-level variation in receipt of aggressive end-of-life care and examined physician-level factors contributing to this variation in the SEER-Medicare data set.

Methods: Medicare beneficiaries with ovarian cancer who died between 2000 and 2016 were included if they were diagnosed after age 66 years, had complete Medicare coverage between diagnosis and death, and had outpatient physician evaluation and management for their ovarian cancer. Using multilevel logistic regression, we examined physician variation in no hospice enrollment, late hospice enrollment (≤ 3 days), > 1 emergency department visit, an intensive care unit stay, terminal hospitalization, > 1 hospitalization, receiving a life-extending or invasive procedure, and chemotherapy (in the last 2 weeks).

Results: In this sample of 6,288 women, 51% of women received at least one form of aggressive end-of-life care. Most common were no hospice enrollment (28.9%), an intensive care unit stay (18.6%), and receipt of an invasive procedure (20.7%). For not enrolling in hospice, 9.9% of variation was accounted for by physician clustering (P < .01). Chemotherapy had the highest physician variation (12.4%), with no meaningful portion of the variation explained by physician specialty, volume, region, or patient characteristics.

Conclusion: In this study, a meaningful amount of variation in aggressive end-of-life care among women dying of ovarian cancer was at the physician level, suggesting that efforts to improve the quality of this care should include interventions aimed at physician practices and decision making in end-of-life care.

PubMed Disclaimer

Conflict of interest statement

Lauren P. WallnerHonoraria: Kaiser PermanenteNo other potential conflicts of interest were reported.

Figures

FIG 1.
FIG 1.
Distribution of aggressive end-of-life care by physician specialty among women dying of ovarian cancer between 2000 and 2016. aP < .05. ED, emergency department; OB GYN, obstetrics and gynecologic; Onc, oncology; ICU, intensive care unit.

References

    1. Wright AA, Keating NL, Ayanian JZ, et al. : Family perspectives on aggressive cancer care near the end of life. JAMA 315:284-292, 2016 - PMC - PubMed
    1. Wright AA, Zhang B, Ray A, et al. : Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665-1673, 2008 - PMC - PubMed
    1. von Gruenigen V, Daly B, Gibbons H, et al. : Indicators of survival duration in ovarian cancer and implications for aggressiveness of care. Cancer 112:2221-2227, 2008 - PubMed
    1. National Quality Forum : NQF-endorsed palliative care and end of life care endorsement maintenance standards. https://www.qualityforum.org/Projects/n-r/Palliative_Care_and_End-of-Lif...
    1. Jacobson JO, Neuss MN, Hauser R: Measuring and improving value of care in oncology practices: ASCO programs from quality oncology practice initiative to the rapid learning system. Am Soc Clin Oncol Ed Book:e70-e76, 2012 - PubMed

Publication types